Gene Review:
PLA2G7 - phospholipase A2, group VII (platelet...
Homo sapiens
Synonyms:
1-alkyl-2-acetylglycerophosphocholine esterase, 2-acetyl-1-alkylglycerophosphocholine esterase, Group-VIIA phospholipase A2, LDL-PLA(2), LDL-PLA2, ...
Tsoukatos,
Liapikos,
Tselepis,
Chapman,
Ninio,
Stafforini,
Numao,
Tsodikov,
Vaitkus,
Fukuda,
Watanabe,
Fueki,
McIntyre,
Zimmerman,
Makino,
Prescott,
Stafforini,
Satoh,
Atkinson,
Tjoelker,
Eberhardt,
Yoshida,
Imaizumi,
Takamatsu,
Zimmerman,
McIntyre,
Gray,
Prescott,
Ninio,
Tregouet,
Carrier,
Stengel,
Bickel,
Perret,
Rupprecht,
Cambien,
Blankenberg,
Tiret,
Howard,
Olson,
- Platelet-activating factor and human meningiomas. Denizot, Y., De Armas, R., Caire, F., Pommepuy, I., Truffinet, V., Labrousse, F. Neuropathol. Appl. Neurobiol. (2006)
- Cloning and expression of a cDNA encoding the beta-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase. Hattori, M., Adachi, H., Aoki, J., Tsujimoto, M., Arai, H., Inoue, K. J. Biol. Chem. (1995)
- A mutation in plasma platelet-activating factor acetylhydrolase (Val279Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension. Yoshida, H., Imaizumi, T., Fujimoto, K., Itaya, H., Hiramoto, M., Yoshimizu, N., Fukushi, K., Satoh, K. Thromb. Haemost. (1998)
- Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation. Yamada, Y., Yokota, M. Biochem. Biophys. Res. Commun. (1997)
- Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Yamada, Y., Ichihara, S., Fujimura, T., Yokota, M. Metab. Clin. Exp. (1998)
- Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected]. Hattori, M., Adachi, H., Tsujimoto, M., Arai, H., Inoue, K. Nature (1994)
- Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. Camussi, G., Tetta, C., Bussolino, F., Baglioni, C. J. Exp. Med. (1988)
- Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. Stafforini, D.M., Numao, T., Tsodikov, A., Vaitkus, D., Fukuda, T., Watanabe, N., Fueki, N., McIntyre, T.M., Zimmerman, G.A., Makino, S., Prescott, S.M. J. Clin. Invest. (1999)
- Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. Stafforini, D.M., Satoh, K., Atkinson, D.L., Tjoelker, L.W., Eberhardt, C., Yoshida, H., Imaizumi, T., Takamatsu, S., Zimmerman, G.A., McIntyre, T.M., Gray, P.W., Prescott, S.M. J. Clin. Invest. (1996)
- Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. Ambrosio, G., Oriente, A., Napoli, C., Palumbo, G., Chiariello, P., Marone, G., Condorelli, M., Chiariello, M., Triggiani, M. J. Clin. Invest. (1994)
- Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis. Takakuwa, T., Endo, S., Nakae, H., Suzuki, T., Inada, K., Yoshida, M., Ogawa, M., Uchida, K. Res. Commun. Chem. Pathol. Pharmacol. (1994)
- Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. Tsukioka, K., Matsuzaki, M., Nakamata, M., Kayahara, H., Nakagawa, T. Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología. (1996)
- PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis. Takakuwa, T., Endo, S., Nakae, H., Kikichi, M., Inada, K., Yoshida, M. Res. Commun. Chem. Pathol. Pharmacol. (1994)
- Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock. Nakae, H., Endo, S., Inada, K., Yaegashi, Y., Takakuwa, T., Yamada, Y., Arakawa, N., Suzuki, T., Taniguchi, S., Shimamura, T., Ogawa, M., Teraoka, H. Res. Commun. Mol. Pathol. Pharmacol. (1996)
- Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. Izaki, S., Yamamoto, T., Goto, Y., Ishimaru, S., Yudate, F., Kitamura, K., Matsuzaki, M. Br. J. Dermatol. (1996)
- Lack of evidence for associations between plasma platelet-activating factor acetylhydrolase deficiency and schizophrenia. Ohtsuki, T., Watanabe, H., Toru, M., Arinami, T. Psychiatry research. (2002)
- Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training. Wootton, P.T., Flavell, D.M., Montgomery, H.E., World, M., Humphries, S.E., Talmud, P.J. Nutrition, metabolism, and cardiovascular diseases : NMCD (2007)
- The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Kruse, S., Mao, X.Q., Heinzmann, A., Blattmann, S., Roberts, M.H., Braun, S., Gao, P.S., Forster, J., Kuehr, J., Hopkin, J.M., Shirakawa, T., Deichmann, K.A. Am. J. Hum. Genet. (2000)
- A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke. Hiramoto, M., Yoshida, H., Imaizumi, T., Yoshimizu, N., Satoh, K. Stroke (1997)
- The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. Howard, K.M., Olson, M.S. J. Biol. Chem. (2000)
- Novel leukocyte agonists are released by endothelial cells exposed to peroxide. Patel, K.D., Zimmerman, G.A., Prescott, S.M., McIntyre, T.M. J. Biol. Chem. (1992)
- Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. Perry, S.W., Hamilton, J.A., Tjoelker, L.W., Dbaibo, G., Dzenko, K.A., Epstein, L.G., Hannun, Y., Whittaker, J.S., Dewhurst, S., Gelbard, H.A. J. Biol. Chem. (1998)
- Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Tew, D.G., Southan, C., Rice, S.Q., Lawrence, M.P., Li, H., Boyd, H.F., Moores, K., Gloger, I.S., Macphee, C.H. Arterioscler. Thromb. Vasc. Biol. (1996)
- PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells. Adachi, T., Aoki, J., Manya, H., Asou, H., Arai, H., Inoue, K. Neurosci. Lett. (1997)
- Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. Desplat, V., Dulery, C., Faucher, J.L., Praloran, V., Denizot, Y. Cancer Lett. (2000)
- Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2. Satoh, K., Imaizumi, T., Kawamura, Y., Yoshida, H., Hiramoto, M., Takamatsu, S., Takamatsu, M. J. Clin. Invest. (1991)
- The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum. Ostermann, G., Kostner, G.M., Gries, A., Malle, E., Till, U. Haemostasis (1989)
- Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Tsoukatos, D.C., Liapikos, T.A., Tselepis, A.D., Chapman, M.J., Ninio, E. Biochem. J. (2001)
- Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. Tanaka, R., Iijima, K., Xu, H., Inoue, Y., Murakami, R., Shirakawa, T., Nishiyama, K., Miwa, M., Shiozawa, S., Nakamura, H., Yoshikawa, N. Am. J. Kidney Dis. (1999)
- Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Ninio, E., Tregouet, D., Carrier, J.L., Stengel, D., Bickel, C., Perret, C., Rupprecht, H.J., Cambien, F., Blankenberg, S., Tiret, L. Hum. Mol. Genet. (2004)
- Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. Marathe, G.K., Zimmerman, G.A., McIntyre, T.M. J. Biol. Chem. (2003)
- Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Montrucchio, G., Bergerone, S., Bussolino, F., Alloatti, G., Silvestro, L., Lupia, E., Cravetto, A., Di Leo, M., Emanuelli, G., Camussi, G. Circulation (1993)
- Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation. Androulakis, N., Durand, H., Ninio, E., Tsoukatos, D.C. J. Lipid Res. (2005)